Efficacy and safety of infliximab in very early onset inflammatory bowel disease: a national comparative retrospective study

SIGENP IBD Working Group

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Efficacy and safety of infliximab in very early onset inflammatory bowel disease: a national comparative retrospective study'. Together they form a unique fingerprint.

Medicine & Life Sciences